Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acid and (+/-)-suprofen: a comparison of kinetics and probe substrate selection.
about
Development of an in vitro system with human liver microsomes for phenotyping of CYP2C9 genetic polymorphisms with a mechanism-based inactivatorIdentification of protein targets of reactive metabolites of tienilic acid in human hepatocytes.Risk assessment of mechanism-based inactivation in drug-drug interactions.Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.Pharmacokinetic drug interactions involving Ginkgo biloba.Mechanism-based inactivation of CYP2C9 by linderane.
P2860
Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acid and (+/-)-suprofen: a comparison of kinetics and probe substrate selection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Mechanism-based inactivation o ...... and probe substrate selection.
@en
type
label
Mechanism-based inactivation o ...... and probe substrate selection.
@en
prefLabel
Mechanism-based inactivation o ...... and probe substrate selection.
@en
P2093
P2860
P356
P1476
Mechanism-based inactivation o ...... and probe substrate selection.
@en
P2093
J Matthew Hutzler
Larissa M Balogh
Michael Zientek
Timothy S Tracy
Vikas Kumar
P2860
P356
10.1124/DMD.108.023358
P577
2008-10-06T00:00:00Z